Ashok Jaiswal

ORCID: 0000-0002-0593-6559 · 2 papers in corpus · active 2024

Study types

  • article 1
  • preprint 1

Condition tags

  • endometriosis 2
  • endometrioma 1
preprint 2024
A multicentre phase III study comparing efficacy & safety of novel extended-release vs. conventional formulation of Dydrogesterone in Indian patients with endometriosis
·doi:10.21203/rs.3.rs-4121316/v1
article 2024
A multicentre phase III study comparing efficacy and safety of novel extended-release versus conventional formulation of dydrogesterone in Indian patients with endometriosis
·doi:10.18203/2320-1770.ijrcog20241298

Background: The aim of the study was to compare the efficacy and safety of novel once-daily extended-release (ER) dydrogesterone 20 mg versus conventional twice-daily dydrogesterone 10 mg in Indian patients with endometriosis. Methods: A ph…